查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1598769

单位剂量製造市场：按产品、来源和最终用户划分 - 全球预测 2025-2030

Unit Dose Manufacturing Market by Product (Liquid Unit Dose, Solid Unit Dose), Sourcing (In-House, Outsourcing), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年单位剂量製造市场价值为233.4亿美元，预计到2024年将达到276.1亿美元，复合年增长率为18.76%，到2030年将达到778.1亿美元。

单位剂量生产涉及生产单独的、预先测量的药物剂量，已成为医疗保健和製药行业不可或缺的一部分。对有效药物管理、病人安全和遵守处方治疗方法的需求日益增长，尤其是在医院和长期照护机构中，这一需求更加突出。应用范围不仅限于药品，还包括营养食品和非处方药，其中使用单位剂量来提高准确性和安全性。最终使用领域包括医院、家庭保健、药局等。影响市场成长的关键因素包括慢性病的增加、遵守药品分销法规、减少用药错误。家庭医疗保健服务的上升趋势和自动化单位剂量包装技术的进步为市场提供了潜在的机会。特别是，智慧包装和自动分配系统的创新是投资成熟的领域。然而，市场面临初始实施成本高昂和需要严格合规的复杂监管环境等限制。此外，整合先进技术需要熟练的人员，鑑于专业医疗保健领域的劳动力差异，这可能是一项艰鉅的挑战。创新和研究应着重于开发具有成本效益和高效的包装解决方案，并整合数位健康技术以增强药物依从性追踪和监控。市场竞争激烈，各公司竞相增强技术力并扩大服务组合。未来的成长路径包括个人化医疗和促进即时资料分析的技术，以实现更好的库存管理和患者治疗效果。对于在单位剂量製造业寻求资金的公司来说，永续包装可以使产品与新兴行业趋势保持一致，注重监管灵活性，并满足行业标准和消费者期望。

主要市场统计
基准年[2023] 233.4亿美元
预测年份 [2024] 276.1亿美元
预测年份 [2030] 778.1亿美元
复合年增长率（%） 18.76%

市场动态：快速发展的单位剂量製造市场的关键市场洞察

供需的动态交互作用正在改变单位剂量製造市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 增加采用单位剂量以减少用药错误
    • 人们越来越认识到单位剂量製造优于重新包装
    • 医药工业快速发展
  • 市场限制因素
    • 原物料价格波动
  • 市场机会
    • 创新的包装技术和交付解决方案
    • 采用固态剂型的连续生产（CM）
  • 市场挑战
    • 与采用生产单位剂量相关的问题

波特五力：驾驭单位剂量製造市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解单位剂量製造市场的外部影响

外部宏观环境因素在塑造单位剂量製造市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解单位剂量製造市场的竞争格局

单位剂量製造市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵单位剂量製造市场供应商的绩效评估

FPNV定位矩阵是评估单位剂量製造市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製单位剂量製造市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，单位剂量製造市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 增加单位剂量的采用以减少用药错误
      • 提高人们对单位剂量生产相对于重新包装的优势的认识
      • 医药工业快速发展
    • 抑制因素
      • 原物料价格波动
    • 机会
      • 创新的包装技术与运输解决方案
      • 采用固态剂型的连续生产（CM）
    • 任务
      • 与采用製造单位剂量相关的问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章单位剂量製造市场：副产品

  • 液体单位剂量
  • 固态单位剂量

第七章单位剂量製造市场（按采购）

  • 公司内部
  • 外包

第八章单位剂量製造市场：依最终用户分类

  • 医院
  • 独立药房
  • 长期照护设施

第九章美洲单位剂量製造市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太单位剂量製造市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲/中东/非洲单位剂量製造市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Amcor PLC
  • American Health Packaging
  • Catalent Inc.
  • Cencora, Inc.
  • Corden Pharma GmbH
  • Medical Packaging Inc., LLC
  • Mikart, LLC
  • Patheon by Thermo Fisher Scientific Inc.
  • The Tapemark Company by LTS Lohmann Therapie-Systeme AG
  • Unither Pharmaceuticals SAS
Product Code: MRR-3A2E844FDFFA

The Unit Dose Manufacturing Market was valued at USD 23.34 billion in 2023, expected to reach USD 27.61 billion in 2024, and is projected to grow at a CAGR of 18.76%, to USD 77.81 billion by 2030.

Unit Dose Manufacturing involves the production of pre-measured, individualized doses of medications and is a vital component within the healthcare and pharmaceutical industries. Its necessity is emphasized by the growing demand for effective medication management, patient safety, and adherence to prescribed therapies, especially in hospitals and long-term care facilities. Applications extend beyond pharmaceuticals into nutraceuticals and over-the-counter medications, leveraging unit doses for precision and safety. End-use sectors include hospitals, home healthcare, and pharmacies. Key factors influencing market growth include increasing chronic disease prevalence, regulatory compliance for medication distribution, and the push for reduced medication errors. The growing trend of home healthcare services and the advancement of automated unit dose packaging technologies present potential opportunities for the market. Notably, technological innovations in smart packaging and automated dispensing systems are areas ripe for investment. However, the market faces limitations such as high initial implementation costs and a complex regulatory landscape that demands rigorous adherence. Moreover, the integration of advanced technologies requires skilled personnel, which can be a challenging factor given the workforce gap in specialized healthcare domains. Innovation and research should focus on developing cost-effective, efficient packaging solutions and integrating digital health technologies that enhance tracking and monitoring of medication adherence. The market's nature is competitive, with companies vying to enhance their technological capabilities and expand their service portfolios. Future growth avenues may include personalized medicine and technologies that facilitate real-time data analytics for better inventory management and patient outcomes. For companies aiming to capitalize on the unit dose manufacturing industry, it is critical to align product offerings with emerging industry trends, focus on regulatory agility, and invest in sustainable packaging solutions that meet both industry standards and consumer expectations.

KEY MARKET STATISTICS
Base Year [2023] USD 23.34 billion
Estimated Year [2024] USD 27.61 billion
Forecast Year [2030] USD 77.81 billion
CAGR (%) 18.76%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Unit Dose Manufacturing Market

The Unit Dose Manufacturing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing adoption of unit doses to reduce medication errors
    • Rising awareness of benefits of manufacturing unit doses over repackaging
    • Rapid development in the pharmaceutical industry
  • Market Restraints
    • Fluctuations in the prices of raw materials
  • Market Opportunities
    • Innovative packaging technologies and delivery solutions
    • Adopting continuous manufacturing (CM) for solid-dose drug products
  • Market Challenges
    • Issues associated with the adoption of manufactured unit doses

Porter's Five Forces: A Strategic Tool for Navigating the Unit Dose Manufacturing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Unit Dose Manufacturing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Unit Dose Manufacturing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Unit Dose Manufacturing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Unit Dose Manufacturing Market

A detailed market share analysis in the Unit Dose Manufacturing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Unit Dose Manufacturing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Unit Dose Manufacturing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Unit Dose Manufacturing Market

A strategic analysis of the Unit Dose Manufacturing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Unit Dose Manufacturing Market, highlighting leading vendors and their innovative profiles. These include Amcor PLC, American Health Packaging, Catalent Inc., Cencora, Inc., Corden Pharma GmbH, Medical Packaging Inc., LLC, Mikart, LLC, Patheon by Thermo Fisher Scientific Inc., The Tapemark Company by LTS Lohmann Therapie-Systeme AG, and Unither Pharmaceuticals SAS.

Market Segmentation & Coverage

This research report categorizes the Unit Dose Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Liquid Unit Dose and Solid Unit Dose.
  • Based on Sourcing, market is studied across In-House and Outsourcing.
  • Based on End-User, market is studied across Hospitals, Independent Pharmacies, and Long Term Care Facility.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing adoption of unit doses to reduce medication errors
      • 5.1.1.2. Rising awareness of benefits of manufacturing unit doses over repackaging
      • 5.1.1.3. Rapid development in the pharmaceutical industry
    • 5.1.2. Restraints
      • 5.1.2.1. Fluctuations in the prices of raw materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovative packaging technologies and delivery solutions
      • 5.1.3.2. Adopting continuous manufacturing (CM) for solid-dose drug products
    • 5.1.4. Challenges
      • 5.1.4.1. Issues associated with the adoption of manufactured unit doses
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Unit Dose Manufacturing Market, by Product

  • 6.1. Introduction
  • 6.2. Liquid Unit Dose
  • 6.3. Solid Unit Dose

7. Unit Dose Manufacturing Market, by Sourcing

  • 7.1. Introduction
  • 7.2. In-House
  • 7.3. Outsourcing

8. Unit Dose Manufacturing Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Independent Pharmacies
  • 8.4. Long Term Care Facility

9. Americas Unit Dose Manufacturing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Unit Dose Manufacturing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Unit Dose Manufacturing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amcor PLC
  • 2. American Health Packaging
  • 3. Catalent Inc.
  • 4. Cencora, Inc.
  • 5. Corden Pharma GmbH
  • 6. Medical Packaging Inc., LLC
  • 7. Mikart, LLC
  • 8. Patheon by Thermo Fisher Scientific Inc.
  • 9. The Tapemark Company by LTS Lohmann Therapie-Systeme AG
  • 10. Unither Pharmaceuticals SAS

LIST OF FIGURES

  • FIGURE 1. UNIT DOSE MANUFACTURING MARKET RESEARCH PROCESS
  • FIGURE 2. UNIT DOSE MANUFACTURING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNIT DOSE MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. UNIT DOSE MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. UNIT DOSE MANUFACTURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. UNIT DOSE MANUFACTURING MARKET DYNAMICS
  • TABLE 7. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY LIQUID UNIT DOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY SOLID UNIT DOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY OUTSOURCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY LONG TERM CARE FACILITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNIT DOSE MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. UNIT DOSE MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023